A Baltimore jury awarded $10 million in damages against University of Maryland Medical System late last month, in wrongful death lawsuit filed over a medication error.
The family of Dennis Allen brought the medical malpractice case against the hospital, alleging that the drug Kayexalate was improperly administered after Allen was admitted for kidney problems in 2013.
Side effects of Kayexalate caused damage to his colon and resulted in Allen’s death.
Kayexalate is classified as a sodium polystyrene sulfonate and is used to treat patients with high levels of potassium in their blood. The prescription medication is taken orally usually between one and four times per day to allow the body to bind potassium in the large intestine so it can be removed naturally. High levels of potassium in the blood can cause heart rhythm issues.